Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Prostatic Artery Embolization: An Update

  • Tiago Bilhim (Department of Interventional Radiology, Saint Louis Hospital)
  • Received : 2022.10.24
  • Accepted : 2022.12.07
  • Published : 2023.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Bilhim T, Pereira JA, Fernandes L, Rio Tinto H, Pisco JM. Angiographic anatomy of the male pelvic arteries. AJR Am J Roentgenol 2014;203:W373-W382
  2. Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol 2012;23:1403-1415
  3. de Assis AM, Moreira AM, de Paula Rodrigues VC, Harward SH, Antunes AA, Srougi M, et al. Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol 2015;38:855-861
  4. Bilhim T, Pisco J, Pinheiro LC, Rio Tinto H, Fernandes L, Pereira JA. The role of accessory obturator arteries in prostatic arterial embolization. J Vasc Interv Radiol 2014;25:875-879
  5. DeMeritt JS, Wajswol E, Wattamwar A, Osiason A, ChervoniKnapp T, Zamudio S. Duplicated prostate artery central gland blood supply: a retrospective analysis and classification system. J Vasc Interv Radiol 2018;29:1595-1600.e9
  6. Zhang JL, Wang MQ, Shen YG, Ye HY, Yuan K, Xin HN, et al. Effectiveness of contrast-enhanced MR angiography for visualization of the prostatic artery prior to prostatic arterial embolization. Radiology 2019;291:370-378
  7. Andrade G, Khoury HJ, Garzon WJ, Dubourcq F, Bredow MF, Monsignore LM, et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol 2017;28:517-521
  8. Burckenmeyer F, Diamantis I, Kriechenbauer T, Lehmann T, Franiel T, Malouhi A, et al. Prostatic artery embolization: influence of cone-beam computed tomography on radiation exposure, procedure time, and contrast media use. Cardiovasc Intervent Radiol 2021;44:1089-1094
  9. Barral M, Gardavaud F, Lassalle L, Ammar MB, Najdawi M, Razakamanantsoa L, et al. Limiting radiation exposure during prostatic arteries embolization: influence of patient characteristics, anatomical conditions, and technical factors. Eur Radiol 2021;31:6471-6479
  10. Svarc P, Hagen T, Waltenburg H, Andersson C, Blackberg M, Baco E, et al. Center experience and other determinants of patient radiation exposure during prostatic artery embolization: a retrospective study in three Scandinavian centers. Eur Radiol 2022;32:2404-2413
  11. Bilhim T, Costa NV, Torres D, Pinheiro LC, Spaepen E. Long-term outcome of prostatic artery embolization for patients with benign prostatic hyperplasia: single-centre retrospective study in 1072 patients over a 10-year period. Cardiovasc Intervent Radiol 2022;45:1324-1336
  12. Goncalves OM, Carnevale FC, Moreira AM, Antunes AA, Rodrigues VC, Srougi M. Comparative study using 100-300 versus 300-500 ㎛ microspheres for symptomatic patients due to enlarged-BPH prostates. Cardiovasc Intervent Radiol 2016;39:1372-1378
  13. Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 ㎛ versus 300-500 ㎛ versus 100- to 300-㎛ + 300- to 500-㎛ embospheres. J Vasc Interv Radiol 2019;30:638-644
  14. Wang MQ, Zhang JL, Xin HN, Yuan K, Yan J, Wang Y, et al. Comparison of clinical outcomes of prostatic artery embolization with 50-㎛ plus 100-㎛ polyvinyl alcohol (PVA) particles versus 100-㎛ PVA particles alone: a prospective randomized trial. J Vasc Interv Radiol 2018;29:1694-1702
  15. Bilhim T, Pisco J, Campos Pinheiro L, Rio Tinto H, Fernandes L, Pereira JA, et al. Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol 2013;24:1595-1602.e1
  16. Insausti I, Galbete A, Lucas-Cava V, de Ocariz AS, Solchaga S, Monreal R, et al. Prostatic artery embolization (PAE) using polyethylene glycol microspheres: safety and efficacy in 81 patients. Cardiovasc Intervent Radiol 2022;45:1339-1348
  17. Maron SZ, Cedillo MA, Sher A, Kim J, Fischman AM. Use of 70-to 150-㎛ radiopaque spherical embolics for prostatic artery embolization. J Vasc Interv Radiol 2020;31:1084-1089
  18. Salet E, Crombe A, Grenier N, Marcelin C, Lebras Y, Jambon E, et al. Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol 2022;45:814-823
  19. Hwang JH, Park SW, Chang IS, Jung SI, Jeon HJ, Lho YS, et al. Comparison of nonspherical polyvinyl alcohol particles and microspheres for prostatic arterial embolization in patients with benign prostatic hyperplasia. Biomed Res Int 2017;2017:8732351
  20. Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology 2016;281:289-300
  21. Malling B, Roder MA, Brasso K, Forman J, Taudorf M, Lonn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol 2019;29:287-298
  22. Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 2016;27:1686-1697.e8
  23. Zumstein V, Betschart P, Vetterlein MW, Kluth LA, Hechelhammer L, Mordasini L, et al. Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol Focus 2019;5:1091-1100
  24. Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2021;44:183-193
  25. Wu X, Zhou A, Heller M, Kohlbrenner R. Prostatic artery embolization versus transurethral resection of the prostate for benign prostatic hyperplasia: a cost-effectiveness analysis. J Vasc Interv Radiol 2022;33:1605-1615
  26. Rink JS, Froelich MF, McWilliams JP, Gratzke C, Huber T, Gresser E, et al. Prostatic artery embolization for treatment of lower urinary tract symptoms: a Markov model-based cost-effectiveness analysis. J Am Coll Radiol 2022;19:733-743
  27. Bilhim T, Betschart P, Lyatoshinsky P, Mullhaupt G, Abt D. Minimally invasive therapies for benign prostatic obstruction: a review of currently available techniques including prostatic artery embolization, water vapor thermal therapy, prostatic urethral lift, temporary implantable nitinol device and aquablation. Cardiovasc Intervent Radiol 2022;45:415-424
  28. Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, et al. Management of non-neurogenic male LUTS. uroweb.org Web site. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts. Accessed October 24, 2022
  29. Foster HE, Dahm P, Kohler TS, Lerner LB, Parsons JK, Wilt TJ, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2019. J Urol 2019;202:592-598
  30. Bilhim T. Long-term PAE results: what do we know. Semin Intervent Radiol 2022;39:577-580